Does CAPREOMYCIN Cause Product use in unapproved indication? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Product use in unapproved indication have been filed in association with CAPREOMYCIN. This represents 5.5% of all adverse event reports for CAPREOMYCIN.
22
Reports of Product use in unapproved indication with CAPREOMYCIN
5.5%
of all CAPREOMYCIN reports
3
Deaths
7
Hospitalizations
How Dangerous Is Product use in unapproved indication From CAPREOMYCIN?
Of the 22 reports, 3 (13.6%) resulted in death, 7 (31.8%) required hospitalization, and 2 (9.1%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPREOMYCIN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does CAPREOMYCIN Cause?
Electrocardiogram qt prolonged (74)
Off label use (53)
Drug resistance (49)
Vomiting (34)
Anaemia (29)
Neuropathy peripheral (28)
Hepatotoxicity (27)
Intentional product use issue (24)
Nausea (24)
Dyspnoea (22)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which CAPREOMYCIN Alternatives Have Lower Product use in unapproved indication Risk?
CAPREOMYCIN vs CAPSAICIN
CAPREOMYCIN vs CAPTOPRIL
CAPREOMYCIN vs CARBAMAZEPINE
CAPREOMYCIN vs CARBETOCIN
CAPREOMYCIN vs CARBIDOPA